Cogent Biosciences, Inc. COGT Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Cogent Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cogent Biosciences, Inc.'s software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cogent Biosciences, Inc.'s software and technology licenses, net?
- Cogent Biosciences, Inc. (COGT) reported software and technology licenses, net of $1.94M in Q1 2026.
- How has Cogent Biosciences, Inc.'s software and technology licenses, net changed year-over-year?
- Cogent Biosciences, Inc.'s software and technology licenses, net decreased by 60.1% year-over-year, from $4.86M to $1.94M.
- What is the long-term trend for Cogent Biosciences, Inc.'s software and technology licenses, net?
- Over 4 years (2021 to 2025), Cogent Biosciences, Inc.'s software and technology licenses, net has grown at a -3.0% compound annual growth rate (CAGR), from $3.73M to $3.3M.